McCormick's Strong Sales Support Unilever's Food Divestiture Progress

What happened

McCormick & Co. reported higher fiscal second-quarter sales as it continues to combine with Unilever's food business, signaling that the divestiture integration is on track. For Unilever, this news validates the strategic move to shed slower-growth food assets and sharpen focus on Beauty & Wellbeing and Personal Care. While the combination is a positive step for the food business's standalone performance, Unilever's core growth remains modest at 3-5% and the stock trades at a rich ~32x P/E. The company is still early in its major transformation, including the Ice Cream demerger and €800m productivity programme, which carry execution risks. Overall, the McCormick data point reduces some uncertainty around the food exit but does not resolve the larger valuation and growth challenges facing Unilever.

Implication

For investors, the McCormick news is a small positive that supports the portfolio reshaping thesis, but the core investment case remains unchanged. Unilever's rich valuation (~$59.5 vs DCF of $42.9) still offers limited margin of safety. Existing holders should maintain patience and monitor the Ice Cream demerger and productivity savings for clearer evidence of value creation. New capital is better deployed on pullbacks or once the transformation shows more tangible results.

Thesis delta

The McCormick sales update does not alter the fundamental thesis that Unilever is a high-quality franchise undergoing necessary but risky transformation. The news modestly lowers execution risk associated with the food business divestiture, but the key uncertainties around Ice Cream separation and organic growth persist. The thesis remains a POTENTIAL SELL given valuation, but the news tilts the risk/reward slightly more favorable, warranting a watchful stance rather than immediate action.